Immutep IMMP
NASDAQ IMMP
$4.72 +0.01 (+0.22%)
As of: Sep 30, 2026 · 11:50 AM EDT

Immutep (IMMP) Revenue (2016 - 2017)

Updated

Immutep (IMMP) recorded Revenue of $10.33 million in the year ended Jun 30, 2026, up 56.1% from $6.62 million a year earlier.

Analysis

Immutep (IMMP) Revenue (2016 - 2017) Analysis & Trends

Starting with the year ended Jun 30, 2009, Immutep's Revenue history includes 14 years.

  • Annual Revenue has a four-year compound annual growth rate of -90.4% (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 is the highest annual Revenue since the year ended Jun 30, 2022.
  • Per Business Quant data, IMMP's Revenue was $6.62 million in the year ended Jun 30, 2025 and $122.03 billion in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Immutep 35.63 Mn 35.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 631,151.14
Mar 31, 2017 1.31 Mn
Jun 30, 2016 -277.77
Mar 31, 2016 260,087.26
API Access

Immutep Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=IMMP&period=max&api_key=YOUR_API_KEY